Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 12, 2009
Patent Application Number
11065631
Date Filed
February 25, 2005
Patent Primary Examiner
Patent abstract
A compound represented by the following formula, a salt thereof or a hydrate of the foregoing has an excellent hepatocyte growth factor receptor (HGFR) inhibitory activity, and exhibits anti-tumor activity, angiogenesis inhibitory activity and cancer metastasis inhibitory activity.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
